Rheonix Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
54
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$183M
- Investors
-
3
Rheonix General Information
Description
Developer of a molecular diagnostics platform designed to expand access to testing and enhance standards of care through automation. The company's platform offers a customizable system with fully automated assays, user-defined reagents, and economical cartridge-based testing, enabling diagnostic laboratories, healthcare providers, and point-of-care settings to perform complex molecular tests efficiently.
Contact Information
Website
www.rheonix.comCorporate Office
- 10 Brown Road
- Suite 103
- Ithaca, NY 14850
- United States
Corporate Office
- 10 Brown Road
- Suite 103
- Ithaca, NY 14850
- United States
Rheonix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC (Series B) | 27-Nov-2023 | $183M | Completed | Generating Revenue | ||
| 14. Debt - PPP | 05-Apr-2020 | Completed | Generating Revenue | |||
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Later Stage VC (Series B) | 29-Sep-2015 | Completed | Generating Revenue | |||
| 11. Grant | 14-Apr-2015 | Completed | Generating Revenue | |||
| 10. Debt - General | 08-Jul-2014 | Completed | Generating Revenue | |||
| 9. Grant | 21-Apr-2014 | Completed | Generating Revenue | |||
| 8. Early Stage VC (Series A) | 19-Dec-2013 | Completed | Generating Revenue | |||
| 7. Grant | 06-Nov-2013 | $500K | $18.5M | Completed | Generating Revenue | |
| 6. Early Stage VC (Series A) | 16-Feb-2012 | $6M | $18.5M | Completed | Startup |
Rheonix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rheonix Comparisons
Industry
Financing
Details
Rheonix Competitors (29)
One of Rheonix’s 29 competitors is Curetis, a Private Equity-Backed company based in Holzgerlingen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Curetis | Private Equity-Backed | Holzgerlingen, Germany | ||||
| Biocartis | Venture Capital-Backed | Mechelen, Belgium | ||||
| Randox Laboratories | Corporation | Crumlin, United Kingdom | ||||
| ChromaCode | Venture Capital-Backed | Carlsbad, CA | ||||
| T2 Biosystems | Formerly VC-backed | Lexington, MA |
Rheonix Patents
Rheonix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7075138-B2 | How to analyze genomic information | Active | 15-May-2017 | ||
| JP-2020519300-A | Method of analyzing genomic information | Active | 15-May-2017 | ||
| AU-2018269780-A1 | Methods of analyzing genomic information | Inactive | 15-May-2017 | ||
| AU-2022203036-A1 | Methods of analyzing genomic information | Inactive | 15-May-2017 | ||
| EP-3625362-A1 | Methods of analyzing genomic information | Inactive | 15-May-2017 | C12Q1/6816 |
Rheonix Signals
Rheonix Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enhanced Capital Partners | Asset Manager | Minority | ||
| NYSERDA | Government | Minority | ||
| National Institute of Dental and Craniofacial Research | Government |
Rheonix Acquisitions (1)
Rheonix’s most recent deal was a Merger/Acquisition with Innovative Biotechnologies International. The deal was made on 31-Dec-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Innovative Biotechnologies International | 31-Dec-2008 | Merger/Acquisition | Business/Productivity Software |
Rheonix FAQs
-
When was Rheonix founded?
Rheonix was founded in 2009.
-
Where is Rheonix headquartered?
Rheonix is headquartered in Ithaca, NY.
-
What is the size of Rheonix?
Rheonix has 54 total employees.
-
What industry is Rheonix in?
Rheonix’s primary industry is Diagnostic Equipment.
-
Is Rheonix a private or public company?
Rheonix is a Private company.
-
What is the current valuation of Rheonix?
The current valuation of Rheonix is .
-
What is Rheonix’s current revenue?
The current revenue for Rheonix is .
-
How much funding has Rheonix raised over time?
Rheonix has raised $243M.
-
Who are Rheonix’s investors?
Enhanced Capital Partners, NYSERDA, and National Institute of Dental and Craniofacial Research have invested in Rheonix.
-
Who are Rheonix’s competitors?
Curetis, Biocartis, Randox Laboratories, ChromaCode, and T2 Biosystems are some of the 29 competitors of Rheonix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process